HUTCHMED (China) Limited Sponsored ADR (HCM)
(Delayed Data from NSDQ)
$18.41 USD
+0.16 (0.88%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $18.42 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Income Statements
Fiscal Year end for HUTCHMED China Limited Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 838 | 426 | 356 | 228 | 205 |
Cost Of Goods | 384 | 311 | 258 | 189 | 160 |
Gross Profit | 454 | 115 | 98 | 39 | 45 |
Selling & Adminstrative & Depr. & Amort Expenses | 435 | 523 | 426 | 236 | 191 |
Income After Depreciation & Amortization | 18 | -408 | -328 | -197 | -146 |
Non-Operating Income | 41 | -2 | 113 | 8 | 6 |
Interest Expense | 1 | 1 | 1 | 1 | 1 |
Pretax Income | 58 | -410 | -216 | -190 | -141 |
Income Taxes | 5 | 0 | 12 | 5 | 3 |
Minority Interest | 0 | 0 | 28 | 10 | 2 |
Investment Gains/Losses | 47 | 50 | 61 | 79 | 41 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 101 | -360 | -167 | -116 | -104 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 101 | -361 | -195 | -126 | -106 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 27 | -399 | -321 | -191 | -141 |
Depreciation & Amortization (Cash Flow) | 8 | 9 | 7 | 6 | 5 |
Income After Depreciation & Amortization | 18 | -408 | -328 | -197 | -146 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 173.84 | 169.43 | 158.54 | 139.59 | 133.14 |
Diluted EPS Before Non-Recurring Items | 0.58 | -2.13 | -1.23 | -0.90 | -0.80 |
Diluted Net EPS (GAAP) | 0.60 | -2.15 | -1.25 | -0.90 | -0.80 |
Fiscal Year end for HUTCHMED China Limited Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |